Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.
Deposition of islet amyloid polypeptide (IAPP) as islet amyloid in type 2 diabetes contributes to loss of beta-cell function and mass, yet the mechanism for its occurrence is unclear. Neprilysin is a metallopeptidase known to degrade amyloid in Alzheimer disease. We previously demonstrated neprilysin to be present in pancreatic islets and now sought to determine whether it plays a role in degrading islet amyloid. We used an in vitro model where cultured human IAPP (hIAPP) transgenic mouse islets develop amyloid and thereby have increased beta-cell apoptosis. Islet neprilysin activity was inhibited or up-regulated using a specific inhibitor or adenovirus encoding neprilysin, respectively. Following neprilysin inhibition, islet amyloid deposition and beta-cell apoptosis increased by 54 and 75%, respectively, whereas when neprilysin was up-regulated islet amyloid deposition and beta-cell apoptosis both decreased by 79%. To determine if neprilysin modulated amyloid deposition by cleaving hIAPP, analysis of hIAPP incubated with neprilysin was performed by mass spectrometry, which failed to demonstrate neprilysin-induced cleavage. Rather, neprilysin may act by reducing hIAPP fibrillogenesis, which we showed to be the case by fluorescence-based thioflavin T binding studies and electron microscopy. In summary, neprilysin decreases islet amyloid deposition by inhibiting hIAPP fibril formation, rather than degrading hIAPP. These findings suggest that targeting the role of neprilysin in IAPP fibril assembly, in addition to IAPP cleavage by other peptidases, may provide a novel approach to reduce and/or prevent islet amyloid deposition in type 2 diabetes.
Zraika
Sakeneh
S
Department of Medicine, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington 98108, USA.
Aston-Mourney
Kathryn
K
Marek
Peter
P
Hull
Rebecca L
RL
Green
Pattie S
PS
Udayasankar
Jayalakshmi
J
Subramanian
Shoba L
SL
Raleigh
Daniel P
DP
Kahn
Steven E
SE
D000682:Amyloid / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D003921:Diabetes Mellitus, Experimental / Q000628:therapy; D005260:Female; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D015260:Neprilysin / Q000737:chemistry / Q000502:physiology*; D010455:Peptides / Q000737:chemistry*; D011485:Protein Binding
D000682:Amyloid; D010455:Peptides; D015260:Neprilysin
Diabetes. 1994 Dec;43(12):1457-61
7958499
FEBS Lett. 1989 Jul 17;251(1-2):261-4
2666169
Diabetologia. 1994 Feb;37(2):188-94
8163054
Methods Enzymol. 1995;248:263-83
7674926
Neurosci Res. 2002 May;43(1):39-56
12074840
Diabetes Res Clin Pract. 1992 Jan;15(1):97-102
1541241
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492-6
8622964
Peptides. 1995;16(4):647-52
7479298
Diabetologia. 2009 Apr;52(4):626-35
19148619
Cell Mol Life Sci. 2009 Apr;66(8):1321-5
19266159
Cell Mol Life Sci. 2008 Aug;65(16):2574-85
18470479
J Biol Chem. 2001 Jul 6;276(27):25612-20
11342542
Biochem J. 2002 May 1;363(Pt 3):697-705
11964170
Horm Metab Res. 1991 Dec;23(12):577-80
1723393
J Biol Chem. 2006 Aug 25;281(34):24566-74
16787929
J Neurosci. 2003 Mar 15;23(6):1992-6
12657655
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5036-40
2195544
Science. 2001 May 25;292(5521):1550-2
11375493
Exp Cell Res. 1989 Aug;183(2):484-93
2670595
Cancer Cell. 2004 Jan;5(1):67-78
14749127
Biochemistry. 2008 Jun 3;47(22):6016-24
18457428
Curr Alzheimer Res. 2008 Apr;5(2):225-31
18393807
J Biol Chem. 2006 Oct 13;281(41):30471-8
16912050
Endocrinology. 1997 Apr;138(4):1736-41
9075738
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5995-6000
17389375
Diabetes. 2007 Feb;56(2):304-10
17259373
J Biol Chem. 2000 Nov 24;275(47):36621-5
10973971
Diabetes. 2000 Dec;49(12):2056-62
11118007
Blood. 1996 Dec 1;88(11):4159-65
8943850
J Biol Chem. 2003 Sep 26;278(39):37314-20
12867419
Anticancer Res. 2002 Sep-Oct;22(5):2533-8
12529960
J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
15292279
Arch Biochem Biophys. 2002 Sep 15;405(2):275-9
12220542
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2046-51
16467158
Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E431-8
15126240
Diabetologia. 1990 May;33(5):285-9
2198187
Diabetes. 1990 May;39(5):634-8
2185112
Diabetologia. 2004 Feb;47(2):240-8
14722647
Diabetes. 2003 Sep;52(9):2315-20
12941771
J Biol Chem. 2004 Mar 19;279(12):11898-905
14704146
J Biol Chem. 2005 Feb 18;280(7):5892-901
15590663
Biochem Biophys Res Commun. 2007 Mar 2;354(1):234-9
17222388
Nat Med. 2000 Feb;6(2):143-50
10655101